Clinical Trial Update: A Prospective Study to Evaluate Revita DMR Post Market Pilot Clinical Follow-Up Registry in Patient With Type 2 Diabetes

View source ↗

Summary

This is an update on a post-market registry evaluating Revita DMR in patients with Type 2 diabetes. The study status is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Revita DMR

Snippet

Sponsor: Fractyl Health Inc. | Conditions: Diabetes Mellitus, Type 2 | Status: SUSPENDED